The Safety, Efficacy, and Immune Response of Multimodal Thermal Therapy in the Treatment of Malignant Liver Tumors

Multimodal thermal therapy (MTT), as an initiative integration of cryotherapy and radiofrequency heating, has been applied to treat various solid tumors. The feasibility and safety for MTT in the treatment of malignant liver tumors is well-established. This prospective, multi-center, randomized controlled clinical study aimed to explore the ablation-induced immune activating response of MTT in the treatment of malignant liver tumors.

Trial Details

NCT ID
NCT07159048
Phase
NA
Sponsor
Fudan University
Status
RECRUITING
Cancer Type
Hepatocellular Carcinoma (HCC) Liver Cancer
Interventions
  • Multimodal Tumor Thermal Therapy System
  • Radiofrequency Ablation System or Microwave Ablation System
Locations (sample)
  • Shanghai, Shanghai Municipality, China|31.22222,121.45806

Key Eligibility Criteria

  • Age of 18-80 years.
  • Clinical diagnosis or pathologic of hepatocellular carcinoma (HCC) or metastatic liver cancers.
  • Intrahepatic lesions with a diameter of ≤5cm, and the number of lesions ≤5.
  • Without extrahepatic metastases; for patients with liver metastases, previously underwent radical resection of the primary lesion without local rec…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Hepatocellular Carcinoma (HCC) Liver Cancer Trials on Trialify →